The purpose of this study is to determine if the blood glucose and insulin responses to a single dose of oral liquid glyburide (a second generation sulfonylurea) can successfully predict those patients with type II diabetes who are true secondary failures on sulfonylurea therapy.
Showing the most recent 10 out of 128 publications